Items where authors include "Aaronson, N.K."

Article

Bancroft, E.K. orcid.org/0000-0002-5482-5660, Page, E.C., Brook, M.N. et al. (36 more authors) (2024) The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers. BJU International, 134 (3). pp. 484-500. ISSN 1464-4096

King, M.T., Viney, R., Pickard, A.S. et al. (13 more authors) (2018) Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. PharmacoEconomics, 36 (2). pp. 225-238. ISSN 1170-7690

Norman, R., Viney, R., Aaronson, N.K. et al. (12 more authors) (2017) Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 26 (8). pp. 2247-2248. ISSN 0962-9343

Costa, D.S.J., Aaronson, N.K., Fayers, P.M. et al. (8 more authors) (2014) Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach. Patient Related Outcome Measures, 5. pp. 119-129. ISSN 1179-271X

Alonso, J., Bartlett, S.J., Rose, M. et al. (14 more authors) (2013) The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health and Quality of Life Outcomes, 11. 210. ISSN 1477-7525

Proceedings Paper

Oort, Q., Koekkoek, J., Aaronson, N.K. et al. (21 more authors) (2022) PL02.4.A International validation study of an EORTC instrument measuring instrumental activities of daily living (IADL) in patients with brain tumours: EORTC IADL-BN32. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii3-ii3.